Health and Healthcare
221 Articles
Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower…
British drug maker AstraZeneca once again rejected a takeover bid from U.S. pharmaceutical giant Pfizer, this one worth $106 billion…
These are the top analyst upgrades, downgrades and initiations for Tuesday, April 22, 2014. They include AMD, ARM Holdings, Barrick…
ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, March 3, 2014.…
ThinkstockHorizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with…
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big…
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…
ThinkstockWith yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact…
Jon OggInvestors are on the hunt for solid research ideas now that stocks have pulled back a bit. 24/7 Wall…
ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…
ThinkstockOver the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66%…
U.S. equity markets opened slightly higher this morning but lost steam in the afternoon to finish with a loss for…
ThinkstockTotal return is always the name of the game when it comes to investing success. Stocks that pay dividends on…
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating…
Our top personal finance-related articles today. Your wallet will thank you later.